Diabetes Care, Vol 23, Issue 9 1236-1241, Copyright © 2000 by American Diabetes Association

ARTICLES

Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. IOEZ Study Group

EJ Bastyr, CA Stuart, RG Brodows, S Schwartz, CJ Graf, A Zagar and KE Robertson
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA. ejbIII@lilly.com

OBJECTIVE: To compare the overall efficacy of combination therapies focused on fasting or postprandial blood glucose in patients with type 2 diabetes not adequately controlled with oral sulfonylurea agents alone. RESEARCH DESIGN AND METHODS: A total of 135 patients were randomly assigned for 3 months to 1 of 3 combination regimens with glyburide (G) that addressed postprandial blood glucose with insulin lispro (L+G), premeal blood glucose with metformin (M+G), or fasting blood glucose (FBG) with bedtime NPH insulin (NPH+G). RESULTS: At end point, HbA1c was significantly lower with all therapies (P = 0.001) and was significantly lower for L+G (7.68+/-0.88%) compared with either NPH+G (8.51+/-1.38%, P = 0.003) or M+G (8.31+/-1.31%, P = 0.025). FBG at end point was significantly lower for NPH+G (8.49+/-2.36 mmol/l) compared with either L+G (10.57+/-1.97 mmol/l, P = 0.001) or M+G (9.69+/-2.89 mmol/l, P = 0.029). The mean 2-h postprandial glucose after a test meal was significantly lower for L+G (10.87+/-2.88 mmol/l) versus NPH+G (12.21+/-3.12 mmol/, P = 0.052) or versus M+G (12.72+/-3.26 mmol/l, P = 0.009). The overall rate of hypoglycemia (episodes per 30 days) was low and not statistically significant between groups (P = 0.156). CONCLUSIONS: Adding a second antihyperglycemic agent, regardless of its timing of action, lowers HbA1c and glucose values. However, when insulin lispro was used to focus on postprandial blood glucose, there was a greater impact on overall metabolic control. These data support the importance of lowering postprandial blood glucose to optimize overall glycemic control and thus improve long-term outcomes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. A.M. Gale, S. D. Beattie, J. Hu, V. Koivisto, and M. H. Tan Recruitment to a Clinical Trial Improves Glycemic Control in Patients With Diabetes Diabetes Care, December 1, 2007; 30(12): 2989 - 2992. [Abstract] [Full Text] [PDF]

				R. R. Holman, K. I. Thorne, A. J. Farmer, M. J. Davies, J. F. Keenan, S. Paul, J. C. Levy, and the 4-T Study Group Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes N. Engl. J. Med., October 25, 2007; 357(17): 1716 - 1730. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Exploring Treatment Strategies for Type 2 Diabetes Diabetes Care, October 1, 2007; 30(10): 2737 - 2745. [Full Text] [PDF]

				E. von Kriegstein, K. von Kriegstein, C. A. Guevara, J. L. Gross, R. I. Henkin, G. T. McMahon, and R. A. Arky Inhaled Insulin for Diabetes Mellitus N. Engl. J. Med., May 17, 2007; 356(20): 2106 - 2108. [Full Text] [PDF]

				Z. T. Bloomgarden Glycemic treatment in type 1 and type 2 diabetes. Diabetes Care, November 1, 2006; 29(11): 2549 - 2555. [Full Text] [PDF]

				P. Lucotti, E. Setola, L. D. Monti, E. Galluccio, S. Costa, E. P. Sandoli, I. Fermo, G. Rabaiotti, R. Gatti, and P. Piatti Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E906 - E912. [Abstract] [Full Text] [PDF]

				J. E. Gerich Clinicians can help their patients control postprandial hyperglycemia as a means of reducing cardiovascular risk. The Diabetes Educator, July 1, 2006; 32(4): 513 - 522. [Abstract] [Full Text] [PDF]

				E. S. Kilpatrick, A. S. Rigby, and S. L. Atkin The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes Diabetes Care, July 1, 2006; 29(7): 1486 - 1490. [Abstract] [Full Text] [PDF]

				C. Robertson Physiologic insulin replacement in type 2 diabetes: optimizing postprandial glucose control. The Diabetes Educator, May 1, 2006; 32(3): 423 - 432. [Abstract] [Full Text] [PDF]

				R. Scognamiglio, C. Negut, S. V. de Kreutzenberg, A. Tiengo, and A. Avogaro Effects of Different Insulin Regimes on Postprandial Myocardial Perfusion Defects in Type 2 Diabetic Patients Diabetes Care, January 1, 2006; 29(1): 95 - 100. [Abstract] [Full Text] [PDF]

				R. J. Heine, L. F. Van Gaal, D. Johns, M. J. Mihm, M. H. Widel, R. G. Brodows, and for the GWAA Study Group* Exenatide versus Insulin Glargine in Patients with Suboptimally Controlled Type 2 Diabetes: A Randomized Trial Ann Intern Med, October 18, 2005; 143(8): 559 - 569. [Abstract] [Full Text] [PDF]

				J. Gerich, P. Raskin, L. Jean-Louis, D. Purkayastha, and M. A. Baron PRESERVE-{beta}: Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin Diabetes Care, September 1, 2005; 28(9): 2093 - 2099. [Abstract] [Full Text] [PDF]

				A. H Frid, M. Nilsson, J. J. Holst, and I. M. Bjorck Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects Am. J. Clinical Nutrition, July 1, 2005; 82(1): 69 - 75. [Abstract] [Full Text] [PDF]

				L. S. Cozma, S. D. Luzio, G. J. Dunseath, P. M. Underwood, and D. R. Owens {beta}-Cell Response During a Meal Test: A comparative study of incremental doses of repaglinide in type 2 diabetic patients Diabetes Care, May 1, 2005; 28(5): 1001 - 1007. [Abstract] [Full Text] [PDF]

				I. B. Hirsch Insulin Analogues N. Engl. J. Med., January 13, 2005; 352(2): 174 - 183. [Full Text] [PDF]

				A. Ceriello Postprandial Hyperglycemia and Diabetes Complications: Is It Time to Treat? Diabetes, January 1, 2005; 54(1): 1 - 7. [Abstract] [Full Text] [PDF]

				A. Ceriello, M. Hanefeld, L. Leiter, L. Monnier, A. Moses, D. Owens, N. Tajima, J. Tuomilehto, and for the International Prandial Glucose Regulation Postprandial Glucose Regulation and Diabetic Complications Arch Intern Med, October 25, 2004; 164(19): 2090 - 2095. [Abstract] [Full Text] [PDF]

				R. J. Schrot Targeting Plasma Glucose: Preprandial Versus Postprandial Clin. Diabetes, October 1, 2004; 22(4): 169 - 172. [Abstract] [Full Text] [PDF]

				D. G. O'Donovan, S. Doran, C. Feinle-Bisset, K. L. Jones, J. H. Meyer, J. M. Wishart, H. A. Morris, and M. Horowitz Effect of Variations in Small Intestinal Glucose Delivery on Plasma Glucose, Insulin, and Incretin Hormones in Healthy Subjects and Type 2 Diabetes J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3431 - 3435. [Abstract] [Full Text] [PDF]

				M. J. Abrahamson Optimal Glycemic Control in Type 2 Diabetes Mellitus: Fasting and Postprandial Glucose in Context Arch Intern Med, March 8, 2004; 164(5): 486 - 491. [Abstract] [Full Text] [PDF]

				V. Fonseca, C. Desouza, S. Asnani, and I. Jialal Nontraditional Risk Factors for Cardiovascular Disease in Diabetes Endocr. Rev., February 1, 2004; 25(1): 153 - 175. [Abstract] [Full Text] [PDF]

				S. R. Salpeter, E. Greyber, G. A. Pasternak, and E. E. Salpeter Risk of Fatal and Nonfatal Lactic Acidosis With Metformin Use in Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis Arch Intern Med, November 24, 2003; 163(21): 2594 - 2602. [Abstract] [Full Text] [PDF]

				S. R. Weiss, S.-L. Cheng, I. A. Kourides, R. A. Gelfand, and W. H. Landschulz Inhaled Insulin Provides Improved Glycemic Control in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Agents: A Randomized Controlled Trial Arch Intern Med, October 27, 2003; 163(19): 2277 - 2282. [Abstract] [Full Text] [PDF]

				A. J. Garber Benefits of Combination Therapy of Insulin and Oral Hypoglycemic Agents Arch Intern Med, August 11, 2003; 163(15): 1781 - 1782. [Full Text] [PDF]

				A. Pilichiewicz, D. O'Donovan, C. Feinle, Y. Lei, J. M. Wishart, L. Bryant, J. H. Meyer, M. Horowitz, and K. L. Jones Effect of Lipase Inhibition on Gastric Emptying of, and the Glycemic and Incretin Responses to, an Oil/Aqueous Drink in Type 2 Diabetes Mellitus J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3829 - 3834. [Abstract] [Full Text] [PDF]

				{blacktriangledown}Nateglinide and {blacktriangledown}repaglinide for type 2 diabetes? DTB, July 1, 2003; 41(7): 52 - 54. [Abstract] [Full Text] [PDF]

				J. E. Gerich Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia Arch Intern Med, June 9, 2003; 163(11): 1306 - 1316. [Abstract] [Full Text] [PDF]

				J. Davidson Should Postprandial Glucose Be Measured and Treated to a Particular Target? Yes. Diabetes Care, June 1, 2003; 26(6): 1919 - 1921. [Full Text] [PDF]

				D. E. DeWitt and I. B. Hirsch Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review JAMA, May 7, 2003; 289(17): 2254 - 2264. [Abstract] [Full Text] [PDF]

				J. B. Buse Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target? No! Diabetes Care, May 1, 2003; 26(5): 1615 - 1618. [Full Text] [PDF]

				Z. T. Bloomgarden Cardiovascular Disease and Diabetes Diabetes Care, January 1, 2003; 26(1): 230 - 237. [Full Text] [PDF]

				R. M. Hoffman, J. H. Shah, C. S. Wendel, W. C. Duckworth, K. D. Adam, S. U. Bokhari, C. Dalton, and G. H. Murata Evaluating Once- and Twice-Daily Self-Monitored Blood Glucose Testing Strategies for Stable Insulin-Treated Patients With Type 2 Diabetes : The Diabetes Outcomes in Veterans Study Diabetes Care, October 1, 2002; 25(10): 1744 - 1748. [Abstract] [Full Text] [PDF]

				S. Salardi, S. Zucchini, R. Santoni, L. Ragni, S. Gualandi, A. Cicognani, and E. Cacciari The Glucose Area Under the Profiles Obtained With Continuous Glucose Monitoring System Relationships With HbAlc in Pediatric Type 1 Diabetic Patients Diabetes Care, October 1, 2002; 25(10): 1840 - 1844. [Abstract] [Full Text] [PDF]

				J. B. Meigs, D. M. Nathan, R. B. D'Agostino Sr, and P. W.F. Wilson Fasting and Postchallenge Glycemia and Cardiovascular Disease Risk: The Framingham Offspring Study Diabetes Care, October 1, 2002; 25(10): 1845 - 1850. [Abstract] [Full Text] [PDF]

				L. S. Cozma, S. D. Luzio, G. J. Dunseath, K. W. Langendorg, T. Pieber, and D. R. Owens Comparison of the Effects of Three Insulinotropic Drugs on Plasma Insulin Levels After a Standard Meal Diabetes Care, August 1, 2002; 25(8): 1271 - 1276. [Abstract] [Full Text] [PDF]

				C. G. Parkin and N. Brooks Is Postprandial Glucose Control Important? Is It Practical In Primary Care Settings? Clin. Diabetes, April 1, 2002; 20(2): 71 - 76. [Abstract] [Full Text] [PDF]

				L. Monnier, C. Colette, R. Rabasa-Lhoret, H. Lapinski, C. Caubel, A. Avignon, and H. Boniface Morning Hyperglycemic Excursions: A constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes Diabetes Care, April 1, 2002; 25(4): 737 - 741. [Abstract] [Full Text] [PDF]

				E. Bonora, F. Calcaterra, S. Lombardi, N. Bonfante, G. Formentini, R. C. Bonadonna, and M. Muggeo Plasma Glucose Levels Throughout the Day and HbA1c Interrelationships in Type 2 Diabetes: Implications for treatment and monitoring of metabolic control Diabetes Care, December 1, 2001; 24(12): 2023 - 2029. [Abstract] [Full Text] [PDF]

				F. R. Kaufman, L. C. Gibson, M. Halvorson, S. Carpenter, L. K. Fisher, and P. Pitukcheewanont A Pilot Study of the Continuous Glucose Monitoring System: Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects Diabetes Care, December 1, 2001; 24(12): 2030 - 2034. [Abstract] [Full Text] [PDF]

				R. K. Campbell, J. R. White, and D. Nomura The Clinical Importance of Postprandial Hyperglycemia The Diabetes Educator, September 1, 2001; 27(5): 624 - 637. [PDF]

				M. Bonneville, J. Colgin, J. A. Nalesnick, J. Perez, and L. Wentz Patient Perceptions of Prandial Oral Therapy for Type 2 Diabetes The Diabetes Educator, September 1, 2001; 27(5): 669 - 677. [Abstract] [PDF]

				V. Montori Targeting postprandial blood glucose concentrations reduced haemoglobin A1c concentrations in type 2 diabetes mellitus Evid. Based Med., May 1, 2001; 6(3): 80 - 80. [Full Text] [PDF]